Ancillary Pathways is a specialty anatomic pathology services company founded by Hadi Yaziji, M.D., an international leader in the fields of immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) testing for pathology. AP’s mission is to provide the necessary resources and expertise for pathology laboratories to initiate, improve, or expand their IHC and FISH testing capabilities for anatomic pathology. We understand that resource limitations are common reasons for outsourcing these valuable tests; AP’s services address the diverse needs of pathology laboratories of all sizes and in all settings. Our experts work collaboratively with you to provide the specific training and logistical support you need for enhancing your laboratory’s IHC and FISH testing capabilities.

Ancillary Pathways is supported by an extensive network of experienced pathologists and scientists with many decades of practical experience in profitable laboratories. Internationally recognized physicians, scientists and technologists make up Ancillary Pathways’ growing Advisory Board:

Hector Battifora, M.D. (Former President, USCAP) Arcadia, CA
Cyril Fisher, M.D. (Chair, Dept of Histopathology, Royal Marsden Hospital), London, UK
Kevin Halling, M.D. (Title, Mayo Clinic), Rochester, MN
Alvin W. Martin, M.D. (Professor, Univ. of Louisville Dept. of Pathology), Lousiville, KY
Richard Cartun, Ph.D. (Treasurer, Society of Applied Immunohistochemistry), Hartford, CT
Sumiko Sumida, H.T. (former President, NSH), Whidbey Island, WA
Nancy Shellhorn, H.T., ASCP (former Regional Sales Manager, Dako), Jacksonville, FL
Sheron Lear, H.T., ASCP (former President, NSH), Louisville, KY
Patsy Ruegg, H.T., ASCP (Director, IHCTech), Aurora, CO